Brighton Jones’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$594K Buy
40,069
+1,954
+5% +$14K 0.01% 726
2026
Q2
$159K Buy
+38,115
New +$145K ﹤0.01% 1277

Other funds holding IOVA

Brighton Jones's IOVA Position: Q3 2026 in Review

Brighton Jones increased its Iovance Biotherapeutics (IOVA) stake by 5.1% in Q3 2026, buying an estimated $14K and bringing the position to 40,069 shares worth $594K. The position accounts for 0.01% of the portfolio, ranked #726.

Brighton Jones first reported a position in IOVA in Q2 2026 and has held it in 2 quarters since. 263 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Brighton Jones held 40,069 shares of Iovance Biotherapeutics worth $594K as of Q3 2026.
  • Brighton Jones bought 1,954 Iovance Biotherapeutics shares in Q3 2026, an estimated $14K.
  • Iovance Biotherapeutics made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #726 holding.
  • Brighton Jones first reported a position in Iovance Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 263 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.